These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 15030744

  • 1. [Azithromycin therapy in cystic fibrosis].
    Máiz Carro L, Cantón Moreno R.
    Med Clin (Barc); 2004 Mar 06; 122(8):311-6. PubMed ID: 15030744
    [Abstract] [Full Text] [Related]

  • 2. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.
    Wolter J, Seeney S, Bell S, Bowler S, Masel P, McCormack J.
    Thorax; 2002 Mar 06; 57(3):212-6. PubMed ID: 11867823
    [Abstract] [Full Text] [Related]

  • 3. Long term azithromycin therapy in patients with cystic fibrosis.
    Emiralioğlu N, Öztürk Z, Yalçın E, Doğru D, Özçelik U, Kiper N.
    Turk J Pediatr; 2016 Mar 06; 58(1):34-40. PubMed ID: 27922234
    [Abstract] [Full Text] [Related]

  • 4. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA, Wolfs TF, Fleer A, Kimpen JL, van der Ent CK.
    Pediatr Infect Dis J; 2007 Jan 06; 26(1):8-12. PubMed ID: 17195698
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of azithromycin in patients with cystic fibrosis.
    Samson C, Tamalet A, Thien HV, Taytard J, Perisson C, Nathan N, Clement A, Boelle PY, Corvol H.
    Respir Med; 2016 Aug 06; 117():1-6. PubMed ID: 27492507
    [Abstract] [Full Text] [Related]

  • 6. The use of macrolide antibiotics in patients with cystic fibrosis.
    Saiman L.
    Curr Opin Pulm Med; 2004 Nov 06; 10(6):515-23. PubMed ID: 15510060
    [Abstract] [Full Text] [Related]

  • 7. Azithromycin for improving pulmonary function in cystic fibrosis.
    Carr RR, Nahata MC.
    Ann Pharmacother; 2004 Sep 06; 38(9):1520-4. PubMed ID: 15213312
    [Abstract] [Full Text] [Related]

  • 8. Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial.
    Kabra SK, Pawaiya R, Lodha R, Kapil A, Kabra M, Vani AS, Agarwal G, Shastri SS.
    J Cyst Fibros; 2010 Jan 06; 9(1):17-23. PubMed ID: 19818694
    [Abstract] [Full Text] [Related]

  • 9. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
    Phaff SJ, Tiddens HA, Verbrugh HA, Ott A.
    J Antimicrob Chemother; 2006 Apr 06; 57(4):741-6. PubMed ID: 16469851
    [Abstract] [Full Text] [Related]

  • 10. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.
    Nguyen D, Emond MJ, Mayer-Hamblett N, Saiman L, Marshall BC, Burns JL.
    Pediatr Pulmonol; 2007 Jun 06; 42(6):533-41. PubMed ID: 17469154
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis.
    Wilms EB, Touw DJ, Heijerman HG.
    Ther Drug Monit; 2006 Apr 06; 28(2):219-25. PubMed ID: 16628134
    [Abstract] [Full Text] [Related]

  • 12. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.
    Saiman L, Marshall BC, Mayer-Hamblett N, Burns JL, Quittner AL, Cibene DA, Coquillette S, Fieberg AY, Accurso FJ, Campbell PW, Macrolide Study Group.
    JAMA; 2003 Oct 01; 290(13):1749-56. PubMed ID: 14519709
    [Abstract] [Full Text] [Related]

  • 13. Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis.
    Tarique AA, Tuladhar N, Kelk D, Begum N, Lucas RM, Luo L, Stow JL, Wainwright CE, Bell SC, Sly PD, Fantino E.
    Cells; 2024 Jan 16; 13(2):. PubMed ID: 38247856
    [Abstract] [Full Text] [Related]

  • 14. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
    Saiman L, Anstead M, Mayer-Hamblett N, Lands LC, Kloster M, Hocevar-Trnka J, Goss CH, Rose LM, Burns JL, Marshall BC, Ratjen F, AZ0004 Azithromycin Study Group.
    JAMA; 2010 May 05; 303(17):1707-15. PubMed ID: 20442386
    [Abstract] [Full Text] [Related]

  • 15. Autoantibodies against bactericidal/permeability-increasing protein (BPI-ANCA) in cystic fibrosis patients treated with azithromycin.
    Rotschild M, Elias N, Berkowitz D, Pollak S, Shinawi M, Beck R, Bentur L.
    Clin Exp Med; 2005 Jul 05; 5(2):80-5. PubMed ID: 16096858
    [Abstract] [Full Text] [Related]

  • 16. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
    Li Y, Huang J, Li L, Liu L.
    Cell Physiol Biochem; 2017 Jul 05; 42(4):1657-1669. PubMed ID: 28738346
    [Abstract] [Full Text] [Related]

  • 17. Long term azithromycin therapy in cystic fibrosis patients: a study on drug levels and sputum properties.
    Baumann U, King M, App EM, Tai S, König A, Fischer JJ, Zimmermann T, Sextro W, von der Hardt H.
    Can Respir J; 2004 Mar 05; 11(2):151-5. PubMed ID: 15045047
    [Abstract] [Full Text] [Related]

  • 18. Azithromycin use in patients with cystic fibrosis.
    Principi N, Blasi F, Esposito S.
    Eur J Clin Microbiol Infect Dis; 2015 Jun 05; 34(6):1071-9. PubMed ID: 25686729
    [Abstract] [Full Text] [Related]

  • 19. Therapy with macrolides in patients with cystic fibrosis.
    Gaylor AS, Reilly JC.
    Pharmacotherapy; 2002 Feb 05; 22(2):227-39. PubMed ID: 11837560
    [Abstract] [Full Text] [Related]

  • 20. Macrolides in cystic fibrosis.
    McArdle JR, Talwalkar JS.
    Clin Chest Med; 2007 Jun 05; 28(2):347-60. PubMed ID: 17467553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.